ORGO - Organogenesis Holdings Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 406.80M
Enterprise value 428.12M
Trailing P/E 25.83
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)0.91
Price/book (mrq)1.53
Enterprise value/revenue 0.93
Enterprise value/EBITDA 11.32

Trading information

Stock price history

Beta (5Y monthly) 1.43
52-week change 3-32.80%
S&P500 52-week change 31.77%
52-week high 36.5200
52-week low 31.7950
50-day moving average 32.3551
200-day moving average 32.8422

Share statistics

Avg vol (3-month) 31.55M
Avg vol (10-day) 31.38M
Shares outstanding 5131.26M
Implied shares outstanding 6N/A
Float 861.14M
% held by insiders 148.70%
% held by institutions 143.38%
Shares short (14 May 2023) 45.15M
Short ratio (14 May 2023) 44.49
Short % of float (14 May 2023) 417.32%
Short % of shares outstanding (14 May 2023) 43.93%
Shares short (prior month 13 Apr 2023) 45.1M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin 2.92%
Operating margin (ttm)5.75%

Management effectiveness

Return on assets (ttm)3.76%
Return on equity (ttm)5.32%

Income statement

Revenue (ttm)461.42M
Revenue per share (ttm)3.53
Quarterly revenue growth (yoy)10.80%
Gross profit (ttm)345.87M
Net income avi to common (ttm)13.48M
Diluted EPS (ttm)0.1000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)88.69M
Total cash per share (mrq)0.68
Total debt (mrq)124.31M
Total debt/equity (mrq)47.14
Current ratio (mrq)2.85
Book value per share (mrq)2.01

Cash flow statement

Operating cash flow (ttm)18.37M
Levered free cash flow (ttm)-13.23M